LAS41008

· Almirall, S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LAS41008, covering 2015-12-02 to 2016-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 [Phase 1]